Carrier-mediated uptake of H2-receptor antagonists by the rat choroid plexus: involvement of rat organic anion transporter 3.
The choroid plexus (CP) acts as a site for the elimination of xenobiotic organic compounds from the cerebrospinal fluid (CSF). The purpose of the present study is to investigate the role of rat organic anion transporter 3 (rOat3; Slc22a8) in the uptake of H(2)-receptor antagonists (cimetidine, ranitidine, and famotidine) by the isolated rat CP. Saturable uptake of cimetidine and ranitidine was observed in rOat3-LLC with K(m) values of 80 and 120 microM, respectively, whereas famotidine was found to be a poor substrate. The steady-state concentration of the H(2)-receptor antagonists in the CSF was significantly increased by simultaneously administered probenecid, although it did not affect their brain and plasma concentrations. Saturable uptake of cimetidine and ranitidine was observed in the isolated rat CP with K(m) values of 93 and 170 microM, respectively, whereas 50% of the uptake of famotidine remained at the highest concentration examined (1 mM). The K(i) value of ranitidine for the uptake of cimetidine by the isolated CP (50 microM) was similar to its own K(m) value, suggesting that they share the same transporter for their uptake. The inhibition potency of organic anions such as benzylpenicillin, estradiol 17beta-glucuronide, p-aminohippurate, and estrone sulfate for the uptake of cimetidine by the isolated rat CP was similar to that for benzylpenicillin, the uptake of which has been hypothesized to be mediated by rOat3, whereas a minimal effect by tetraethylammonium excludes involvement of organic cation transporter(s). These results suggest that rOat3 is the most likely candidate transporter involved in regulating the CSF concentration of H(2)-receptor antagonists at the CP.
Graduate School of Pharmaceutical Sciences, the University of Tokyo, 7-3-1, Hongo, Bunkyo-ku, Tokyo 113-0033, Japan.
Yoshinori
Y
Nagata
Hiroyuki
H
Kusuhara
Shuichi
S
Hirono
Hitoshi
H
Endou
Yuichi
Y
Sugiyama
D000818:Animals; D002250:Carbon Radioisotopes; D002352:Carrier Proteins / Q000187:drug effects* / Q000378:metabolism*; D002555:Cerebrospinal Fluid / Q000737:chemistry / Q000187:drug effects / Q000378:metabolism; D002831:Choroid Plexus / Q000166:cytology / Q000187:drug effects* / Q000378:metabolism*; D002927:Cimetidine / Q000378:metabolism / Q000494:pharmacology; D004305:Dose-Response Relationship, Drug; D015738:Famotidine / Q000037:antagonists & inhibitors / Q000378:metabolism / Q000494:pharmacology; D006635:Histamine H2 Antagonists / Q000737:chemistry / Q000494:pharmacology*; D008297:Male; D008958:Models, Molecular; D015394:Molecular Structure; D027701:Organic Cation Transport Proteins / Q000037:antagonists & inhibitors / Q000187:drug effects / Q000378:metabolism*; D010400:Penicillin G / Q000378:metabolism / Q000494:pharmacology; D011339:Probenecid / Q000097:blood / Q000494:pharmacology; D011899:Ranitidine / Q000037:antagonists & inhibitors / Q000378:metabolism / Q000494:pharmacology; D051381:Rats; D017207:Rats, Sprague-Dawley; D055672:Static Electricity; D019789:Tetraethylammonium / Q000494:pharmacology; D014316:Tritium; D000099254:Organic Cation Transporter 3
D002250:Carbon Radioisotopes; D002352:Carrier Proteins; D002927:Cimetidine; D015738:Famotidine; D006635:Histamine H2 Antagonists; D027701:Organic Cation Transport Proteins; D010400:Penicillin G; D011339:Probenecid; D011899:Ranitidine; D019789:Tetraethylammonium; D014316:Tritium; D000099254:Organic Cation Transporter 3